Loading field map
Payment and incentives is a subfield of health services research concerned with how the financial arrangements that fund healthcare shape the behavior of patients, clinicians, hospitals, and insurers—and, through those behaviors, the cost, quality, and accessibility of care. Its central premise is that the way money flows through a health system is not a neutral administrative detail. Payment rules create incentives, and those incentives influence clinical decisions, organizational strategies, and ultimately health outcomes. The field studies these relationships empirically, designs and evaluates alternative payment models, and informs the policy choices that determine how healthcare is bought and sold.
The field is organized around a small set of enduring questions. How should payers—governments, employers, private insurers—compensate providers for the services they deliver? What behaviors do different payment methods encourage or discourage? How do providers respond when financial risk is shifted onto them, or when rewards are tied to quality metrics? And what are the trade-offs among cost control, quality improvement, access, and administrative burden?
These questions matter because healthcare is not a normal market. Patients often lack the information to judge the quality or necessity of care, and they are frequently insulated from its cost by insurance. Clinicians act as agents for patients, but their decisions are shaped by their own financial circumstances. This creates a persistent tension: payment systems must motivate providers to deliver appropriate care without rewarding unnecessary care, and to control costs without stinting on needed services. Getting this balance wrong has measurable consequences—in the form of unnecessary procedures, avoidable hospital readmissions, under-treatment of chronic conditions, or the financial strain that medical bills place on households.
The modern study of payment and incentives emerged in the second half of the twentieth century, alongside the expansion of third-party payment for healthcare. Before widespread insurance, patients typically paid clinicians directly for services, and the incentive problem was comparatively simple. The rise of employer-sponsored insurance in the United States and publicly funded systems in other wealthy countries changed the landscape: a third party now bore the cost of care, and providers had new reasons to deliver more services than clinical need alone would justify.
Early health services researchers drew on economic concepts of moral hazard and agency theory to analyze these arrangements. The key insight was that fee-for-service payment—in which providers are paid for each service they deliver—creates an incentive to deliver more services, while capitation—in which providers receive a fixed payment per patient regardless of services used—creates an incentive to deliver fewer. This framing, developed in the 1960s and 1970s, remains foundational. The field's empirical turn came as researchers gained access to large administrative datasets linking payments, utilization, and outcomes, allowing them to measure how providers actually responded to financial incentives rather than merely theorize about it.
The policy context also shaped the field's development. In the United States, the introduction of Medicare's prospective payment system for hospitals in the 1980s—which paid a fixed amount per admission based on diagnosis rather than actual costs—provided a natural experiment that researchers studied intensively. Later, the managed care era of the 1990s, with its emphasis on capitation and utilization review, generated a wave of research on how providers and patients responded to tighter financial constraints. More recently, the shift toward value-based payment—tying reimbursement to quality and outcomes rather than volume—has become a major focus of both policy experimentation and academic study.
The field is not organized into sharply defined rival schools, but rather into several overlapping research traditions that differ in their assumptions, methods, and objects of study. These traditions coexist and often inform one another.
The oldest and most theoretically grounded approach treats providers as rational actors responding to financial incentives. Researchers in this tradition build models of how physicians, hospitals, and other providers weigh the financial consequences of their decisions, then test those models against observational data. The organizing assumption is that providers are not purely altruistic nor purely profit-seeking, but that their behavior responds systematically to changes in the rewards and penalties they face.
This approach has produced a robust body of findings. Fee-for-service payment is associated with higher utilization of services, including some that are of questionable medical value. Capitation is associated with lower utilization, but also with concerns about under-provision of necessary care. The introduction of prospective payment for hospitals shortened lengths of stay and shifted some care to outpatient settings. These findings are generally consistent across studies, though the magnitude of effects varies with context.
The limits of this approach are also well understood. Providers are not purely financial actors; professional norms, fear of malpractice, patient expectations, and clinical uncertainty all shape decisions. Financial incentives interact with these factors in complex ways, and the same payment system can produce different behaviors in different settings. Moreover, observational studies struggle to separate the effect of payment from the effect of other simultaneous changes in the healthcare environment.
A second tradition, drawing on behavioral economics and organizational sociology, complicates the rational-actor model. Researchers in this vein study how payment incentives are filtered through human psychology, organizational culture, and institutional structures. They ask why some payment reforms succeed in changing behavior while others fail, and why providers sometimes respond to incentives in ways that the designers did not anticipate.
This approach has highlighted several phenomena that pure economic models miss. Clinicians may respond more strongly to the salience of an incentive than to its size. Organizations may game quality metrics by selecting easier patients or by improving documentation rather than actual care. The way payment reforms are implemented—whether they are perceived as punitive or supportive, whether they align with professional values—affects their uptake. These insights have led to a more nuanced understanding of payment design, emphasizing the importance of implementation, measurement, and the alignment of financial and non-financial motivations.
A third tradition is more applied and pragmatic. Researchers in this vein evaluate specific payment reforms—natural experiments in policy—and use the results to refine future designs. This work is often conducted in partnership with government agencies or insurers, and it tends to be organized around particular payment models rather than around theoretical questions.
The most prominent recent example is the study of accountable care organizations (ACOs) and other value-based payment models. ACOs are networks of providers who accept responsibility for the cost and quality of care for a defined patient population, with the opportunity to share in savings if they meet quality thresholds. Researchers have studied whether ACOs reduce spending, improve quality, or both; whether they achieve savings through genuine care improvements or through patient selection and stinting; and which organizational features predict success. The findings are mixed: some ACOs have generated modest savings, but the overall effects on cost and quality have been smaller than early proponents hoped.
This tradition also includes research on pay-for-performance programs, which reward providers for meeting specific quality targets. The evidence here is sobering: most studies find small or negligible improvements in the targeted outcomes, and some find unintended consequences such as neglect of non-targeted areas or gaming of the measures. These findings have led to a more cautious approach to incentive design, emphasizing the importance of measuring what matters, avoiding perverse incentives, and recognizing the limits of financial motivation.
A fourth tradition examines payment systems across countries and health system structures. This work asks how payment incentives interact with the broader institutional context—the organization of insurance markets, the degree of government regulation, the structure of provider organizations, and the professional culture of medicine.
This comparative lens reveals that the same payment mechanism can have very different effects in different settings. Fee-for-service in a system with strong primary care gatekeeping and global budgets may not produce the same volume inflation as in a system with fragmented financing and weak regulation. Capitation in a system with strong quality oversight may not produce the same stinting as in a system with little accountability. The institutional context determines not only the strength of financial incentives but also the availability of countervailing pressures.
This tradition also highlights the diversity of payment arrangements across countries. Many European and Asian systems combine capitation for primary care with fee-for-service or case-based payment for hospitals, within a framework of global budgets or rate regulation. The United States has historically relied more heavily on fee-for-service, though with increasing experimentation with alternative models. Low- and middle-income countries face additional challenges, including weak administrative capacity, large informal sectors, and the need to incentivize providers to serve poor and rural populations.
The current landscape of payment and incentives research reflects the accumulation of these traditions. Several features are likely to persist.
First, the field has moved away from the belief that any single payment method is optimal. The early debates between fee-for-service and capitation have given way to a more pragmatic search for combinations and hybrids. Most contemporary payment models blend elements: a base payment to ensure financial stability, performance-based bonuses to reward quality, and risk-sharing arrangements to encourage efficiency. The design question is not which pure form to choose, but how to balance the incentives of each component.
Second, there is growing attention to the measurement problem. Payment incentives are only as good as the metrics they are tied to. Researchers have documented the many ways that quality measures can be gamed, the difficulty of risk-adjusting payments fairly, and the unintended consequences of tying money to specific targets. This has led to interest in broader outcome measures, patient-reported outcomes, and composite measures that are harder to manipulate.
Third, the field is increasingly attentive to equity. Payment systems can exacerbate or mitigate disparities in access and quality across racial, ethnic, socioeconomic, and geographic groups. Researchers are studying how payment reforms affect different populations, and how incentives can be designed to reduce rather than reinforce inequities. This is a relatively recent development, but it is likely to become more central.
Fourth, the rise of new care delivery models—telehealth, retail clinics, hospital-at-home programs, and artificial intelligence tools—is creating new payment questions. How should these services be reimbursed? What incentives do different payment approaches create for their adoption and use? The field is beginning to address these questions, though the evidence base is still thin.
Finally, the field remains closely tied to policy. Payment reform is one of the few levers that governments and insurers can pull to influence healthcare delivery, and the demand for evidence to guide those decisions is unlikely to diminish. The relationship between researchers and policymakers is not always comfortable—evaluations often produce inconvenient findings—but it is durable.
The study of payment and incentives is thus a field of modest ambitions and substantial practical importance. It does not promise to solve the problems of healthcare financing, but it offers a rigorous way to understand how financial arrangements shape behavior, and it provides the evidence base for the ongoing, iterative process of payment reform. Its central lesson, accumulated over decades of research, is that incentives matter—but they matter in ways that are context-dependent, often unintended, and never sufficient on their own to produce a well-functioning health system.